RVTY
REVVITY, INC
Laboratory Analytical Instruments- 売上
- $2.9bn
- 時価総額
- $13.6bn
株価 $113.54 · 100株 1万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $2.8bn | $2.8bn | $2.9bn |
| 成長率 | — | 0.2% | 3.7% |
| 総利益 | $2.0bn | $2.0bn | $2.0bn |
| 総利益率 | 72.3% | 72.2% | 69.7% |
| 販管費 | $1.0bn | $994m | $992m |
| 販管費率 | 37.2% | 36.1% | 34.7% |
| 営利 | $301m | $347m | $357m |
| 営利率 | 10.9% | 12.6% | 12.5% |
| 純利益 | $693m | $270m | $241m |
| PBR | 1.7 | 1.8 | 1.9 |
| PSR | 5.0 | 5.0 | 4.8 |
| PGPR | 6.9 | 6.9 | 6.9 |
| PER | 20 | 50 | 57 |
| ﾈｯﾄｷｬｯｼｭ | ▲$3.0bn | ▲$2.0bn | ▲$2.3bn |
| EV/EBITDA | 22.7 | 20.2 | 20.9 |
| Rule of 40 | — | 13% | 16% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）